Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes the cytosolic form of serine hydroxymethyltransferase, a pyridoxal phosphate-containing enzyme that catalyzes the reversible conversion of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate. This reaction provides one-carbon units for synthesis of methionine, thymidylate, and purines in the cytoplasm. This gene is located within the Smith-Magenis syndrome region on chromosome 17. A pseudogene of this gene is located on the short arm of chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
SHMT1 (Serine Hydroxymethyltransferase 1) is a Protein Coding gene. Diseases associated with SHMT1 include Adult Acute Lymphocytic Leukemia and Smith-Magenis Syndrome. Among its related pathways are Glycine, serine and threonine metabolism and One carbon pool by folate. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and pyridoxal phosphate binding. An important paralog of this gene is SHMT2.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000900 | translation repressor activity, mRNA regulatory element binding | IDA | 10995219 |
GO:0003824 | catalytic activity | IEA | -- |
GO:0004372 | glycine hydroxymethyltransferase activity | IEA,IDA | 8505317 |
GO:0004843 | thiol-dependent ubiquitin-specific protease activity | IEA | -- |
GO:0005515 | protein binding | IPI | 25416956 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005634 | nucleus | IBA | 21873635 |
GO:0005654 | nucleoplasm | IDA | -- |
GO:0005737 | cytoplasm | IBA | 21873635 |
GO:0005829 | cytosol | TAS | -- |
GO:0070062 | extracellular exosome | HDA | 19056867 |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | One carbon pool by folate | ||
2 | Metabolism of water-soluble vitamins and cofactors | ||
3 | Glycine, serine and threonine metabolism | ||
4 | Carbon metabolism | ||
5 | Metabolism |
.40
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006508 | proteolysis | IEA | -- |
GO:0006544 | glycine metabolic process | IDA | 24698160 |
GO:0006545 | glycine biosynthetic process | IEA | -- |
GO:0006563 | L-serine metabolic process | IDA | 24698160 |
GO:0006565 | L-serine catabolic process | IBA,IDA | 17482557 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Glycine | Approved, Vet_approved | Nutra | Target, product of | 202 | ||
Pyridoxal Phosphate | Approved, Investigational | Nutra | Target, cofactor | 17 | ||
Bevacizumab | Approved, Investigational | Pharma | VEGF antagonist, Therapeutic Antibodies, Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors | 2478 | ||
Fluorouracil | Approved | Pharma | RNA processing inhibitor and thymidylate synthase inhibitor | 2421 | ||
Irinotecan | Approved, Investigational | Pharma | Topoisomerase I inhibitor, TOPO I inhibitor, Topoisomerase 1 Inhibitors | 1482 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
5,10-Methylenetetrahydromethanopterin |
|
|
||||
5,10-Methylene-THF |
|
31690-11-6 |
|
|||
5,6,7,8-Tetrahydromethanopterin |
|
|
ExUns: | 1a | · | 1b | · | 1c | · | 1d | ^ | 2 | ^ | 3 | ^ | 4a | · | 4b | ^ | 5 | ^ | 6 | ^ | 7a | · | 7b | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11 | ^ | 12 | ^ | 13 | ^ | 14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | ||||||||||||||||||||||||||||||||||
SP2: | - | - | - | - | |||||||||||||||||||||||||||||||||
SP3: | - | - | |||||||||||||||||||||||||||||||||||
SP4: | - | - | |||||||||||||||||||||||||||||||||||
SP5: | - |
This gene was present in the common ancestor of eukaryotes.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | SHMT1 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | SHMT1 30 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | SHMT1 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | SHMT1 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Shmt1 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Shmt1 30 |
|
||
Oppossum (Monodelphis domestica) |
Mammalia | SHMT1 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | SHMT1 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | SHMT1 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | shmt1 30 |
|
||
Str.15846 30 |
|
||||
African clawed frog (Xenopus laevis) |
Amphibia | shmt1-prov 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | shmt1 30 31 |
|
OneToOne | |
zgc66171 30 |
|
||||
Fruit Fly (Drosophila melanogaster) |
Insecta | CG3011 30 31 32 |
|
OneToMany | |
African malaria mosquito (Anopheles gambiae) |
Insecta | AgaP_AGAP001065 30 |
|
||
Worm (Caenorhabditis elegans) |
Secernentea | mel-32 30 31 32 |
|
OneToMany | |
A. gosspyii yeast (Eremothecium gossypii) |
Saccharomycetes | AGOS_ACR215C 30 |
|
||
K. Lactis Yeast (Kluyveromyces lactis) |
Saccharomycetes | KLLA0F08921g 30 |
|
||
Baker's yeast (Saccharomyces cerevisiae) |
Saccharomycetes | SHM2 30 31 |
|
ManyToMany | |
SHM1 31 |
|
ManyToMany | |||
Thale Cress (Arabidopsis thaliana) |
eudicotyledons | SHM2 30 |
|
||
Alicante grape (Vitis vinifera) |
eudicotyledons | Vvi.8061 30 |
|
||
Barley (Hordeum vulgare) |
Liliopsida | Hv.2416 30 |
|
||
Corn (Zea mays) |
Liliopsida | Zm.3136 30 |
|
||
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
OneToOne | |
Bread mold (Neurospora crassa) |
Ascomycetes | NCU02274 30 |
|
||
Fission Yeast (Schizosaccharomyces pombe) |
Schizosaccharomycetes | SPAC24C9.12c 30 |
|
||
Sea Vase (Ciona intestinalis) |
Ascidiacea | Cin.4793 30 |
|
SNP ID | Clinical significance and condition | Chr 17 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs115185998 | Likely Benign: not provided | 18,340,220(-) |
G/A NM_004169.5(SHMT1):c.637C>T (p.Arg213Trp) |
MISSENSE | |
rs115557642 | Benign: not provided | 18,335,678(-) |
G/A NM_004169.5(SHMT1):c.815-3C>T |
INTRON | |
rs116100382 | Benign: not provided | 18,328,822(-) |
G/A NM_004169.5(SHMT1):c.1380C>T (p.Ala460=) |
SYNONYMOUS | |
rs141575508 | Benign: not provided. Benign: not provided | 18,340,104(-) |
C/TC/G NM_004169.5(SHMT1):c.753G>A (p.Val251=) |
SYNONYMOUS | |
rs143807950 | Likely Benign: not provided. Benign: not provided | 18,355,980(-) |
A/CA/T NM_004169.5(SHMT1):c.2T>G (p.Met1Arg) |
INITIATIOR_CODON_VARIANT,MISSENSE_VARIANT,FIVE_PRIME_UTR |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv1004827 | CNV | deletion | 20482838 |
esv2758677 | CNV | gain+loss | 17122850 |
esv3640147 | CNV | loss | 21293372 |
nsv1129384 | OTHER | inversion | 24896259 |
nsv155 | OTHER | inversion | 15895083 |
nsv1998 | CNV | insertion | 18451855 |
nsv428333 | CNV | gain | 18775914 |
nsv481238 | CNV | novel sequence insertion | 20440878 |
nsv499114 | OTHER | inversion | 21111241 |
nsv509653 | CNV | insertion | 20534489 |
nsv827913 | CNV | gain | 20364138 |
nsv833386 | CNV | gain | 17160897 |
nsv833387 | CNV | loss | 17160897 |
Disorder | Aliases | PubMed IDs |
---|---|---|
adult acute lymphocytic leukemia |
|
|
smith-magenis syndrome |
|
|
neural tube defects |
|
|
lacrimal gland carcinoma |
|
|
pediatric osteosarcoma |
|
|